| Feb 2, 2023 |
Feb 7, 2023 |
Viridian Therapeutics, Inc.\DE
|
CEO |
Sell |
23.8
|
-50,000
|
-9.42%
|
✓
|
$1.8M |
| Feb 2, 2023 |
Feb 3, 2023 |
Viridian Therapeutics, Inc.\DE
|
CEO |
Sell |
20.0
|
-50,000
|
-10.40%
|
✓
|
$1.8M |
| Jun 1, 2022 |
Jun 2, 2022 |
Viridian Therapeutics, Inc.\DE
|
CEO |
Sell |
30.0
|
-30,000
|
-5.87%
|
✓
|
$366K |
| May 2, 2022 |
May 4, 2022 |
Viridian Therapeutics, Inc.\DE
|
CEO |
Sell |
30.0
|
-30,000
|
-5.55%
|
✓
|
$391.2K |
| Apr 1, 2022 |
Apr 5, 2022 |
Viridian Therapeutics, Inc.\DE
|
CEO |
Sell |
30.0
|
-30,000
|
-5.25%
|
✓
|
$567.6K |
| Mar 1, 2022 |
Mar 3, 2022 |
Viridian Therapeutics, Inc.\DE
|
CEO |
Sell |
35.0
|
-30,000
|
-4.99%
|
✓
|
$529.5K |
| Feb 1, 2022 |
Feb 3, 2022 |
Viridian Therapeutics, Inc.\DE
|
CEO |
Sell |
35.0
|
-30,000
|
-4.76%
|
✓
|
$572.8K |